Skip to main content
OpenTrials

Clinical trial condition

Leukemia

Explore clinical trials studying Leukemia. Study availability and eligibility vary by location and protocol.

4,408 public trials 1,033 recruiting studies
Refine in advanced search Browse all conditions

Leukemia trial results

Active, Not Recruiting

Sequential Treatment With Ponatinib and Blinatumomab vs Chemotherapy and Imatinib in Newly Diagnosed Adult Ph+ ALL

NCT04722848

Conditions
ALL, Adult, Acute Lymphoblastic Leukemia (Philadelphia Chromosome Positive), Hematologic Diseases, +11 more
Locations
  • Area Vasta N. 5 Ascoli Piceno - S. Benedetto Del Tronto, Presidio Ospedaliero Av5 Osp. Gen. Prov.Le "C.G.Mazzoni" - Uoc Ematologia Ascoli Piceno, Italy
  • Irccs Oncologico Istituto Tumori Giovanni Paolo Ii - Bari - Uo Ematologia Bari, Italy
  • Asst Papa Giovanni Xxiii - Ospedale Di Bergamo - Sc Ematologia Bergamo, Italy
  • As Dell'Alto Adige, Ospedale Centrale Di Bolzano - Ematologia E Centro Trapianto Midollo Osseo Bolzano, Italy
View all 15 locations
View Trial Details
Active, Not Recruiting

A Study Evaluating the Safety and Efficacy of BEAM-201 in Relapsed/Refractory T-Cell Acute Lymphoblastic Leukemia (T-ALL) or T-Cell Lymphoblastic Lymphoma (T-LL)

NCT05885464

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
Locations
  • Stanford University School of Medicine Stanford, California, United States
  • Colorado Blood Cancer Institute Denver, Colorado, United States
  • University of Chicago Chicago, Illinois, United States
  • The University of Kansas Cancer Center Fairway, Kansas, United States
View Trial Details
Active, Not Recruiting

Venetoclax and Decitabine Assessment in Patients (≥60 - <75 Years) with Newly Diagnosed AML Eligible for Allo-SCT

NCT04476199

Conditions
Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • USD, Trapianti di Midollo osseo, Azienda Spedali Civili di Brescia Brescia, Italy
  • Unità Terapia Intensiva Ematologica e terapia cellulari - casa della sofferenza San Giovanni Rotondo, Foggia, Italy
  • UO Ematologia e TMO - Ospedale C. Panico Tricase, Lecce, Italy
  • Ospedale San Gerardo Monza, Italy
View all 25 locations
View Trial Details
Active, Not Recruiting

Study to Evaluate the Reinduction and Second Stop of TKI with Ponatinib in CML in Molecular Response (ResToP)

NCT04160546

Conditions
Bone Marrow Diseases, Chronic Disease, Chronic Myeloid Leukemia, Chronic Phase, +12 more
Locations
  • Institut Català D'Oncologia L'Hospitalet (ICO) L'Hospitalet de Llobregat, Barcelona, Spain
  • Hospital General Universitario Gregorio Marañón Madrid, Spain
  • Hospital Ramón y Cajal Madrid, Spain
  • Hospital Universitario y Politécnico La Fe Valencia, Spain
View all 13 locations
View Trial Details
Active, Not Recruiting

NKX101, Intravenous Allogeneic CAR NK Cells, in Adults With AML or MDS

NCT04623944

Conditions
AML, Adult, Bone Marrow Diseases, Hematologic Diseases, +10 more
Locations
  • Colorado Blood Cancer Institute Denver, Colorado, United States
  • Mayo Clinic Florida Jacksonville, Florida, United States
  • Winship Cancer Institute, Emory University Atlanta, Georgia, United States
  • University of Chicago Medical Center Chicago, Illinois, United States
View Trial Details
Active, Not Recruiting

A Study of Gilteritinib Versus Midostaurin in Combination With Induction and Consolidation Therapy Followed by One-year Maintenance in Patients With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndromes With Excess Blasts-2 With FLT3 Mutations Eligible for Intensive Chemotherapy

NCT04027309

Conditions
Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +6 more
Locations
  • AU-Adelaide-FLINDERS Adelaide, Australia
  • AU-Adelaide-RAH Adelaide, Australia
  • AU-Brisbane-PAH Brisbane, Australia
  • AU-Brisbane-RBWH Brisbane, Australia
View all 193 locations
View Trial Details
Active, Not Recruiting

Study of IMGN632 in Patients With Untreated BPDCN and Relapsed/Refractory BPDCN

NCT03386513

Conditions
Blastic Plasmacytoid Dendritic Cell Neoplasm, Bone Marrow Diseases, Disease Attributes, +25 more
Locations
  • Banner Health MD Anderson Cancer Center Gilbert, Arizona, United States
  • City of Hope Medical Center Duarte, California, United States
  • UCLA Los Angeles, California, United States
  • Stanford Stanford, California, United States
View all 28 locations
View Trial Details

Related conditions